365297
06/16/2022
Shelby Skilled Nursing and Rehabilitation
705 Fulton Street Sidney, OH 45365
F 0756
Level of Harm - Minimal harm or potential for actual harm
Residents Affected - Few
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
Based on resident record review, staff interview, and review of a facility policy; the facility failed to respond to pharmacy medication regimen reviews in a timely manner. This affected one (#16) of five residents reviewed for unnecessary medications. The facility census was 36.
Findings include: Medical record review for Resident #16 revealed admission date 10/08/07. Diagnoses included dementia with behavioral disturbance and presence of right artificial knee joint. Review of physician orders dated 04/29/21 revealed Doxycycline 100 milligrams (mg) two times a day for infection, end date 08/30/21. Review of physician orders dated 11/23/21 revealed Memantine 5 mg give two tablets by mouth one time a day and give one tablet by mouth at bedtime. Review of the Consultation Report dated 06/10/21 revealed repeated recommendation from 04/29/21. Resident receives Doxycycline 100 milligrams (mg) orally twice a day since 04/20/21. The order does not list a stop date. Physician's Response: I have re-evaluated this therapy and wish to implement the following changes: Stop Doxy, undated. Review of the Consultation Report dated 08/03/21 revealed Resident receives Memantine Hydrochloride 5 mg two times a day and has tolerated treatment for at least one continuous week. No orders were found in the medical record to up-titrate the dose. Please up-titrate the dose as follows: 10 mg each morning (AM) and 5 mg each nighttime (PM) for seven days, then 10 mg twice daily as a maintenance dose. Rationale for recommendation: The usual dose of memantine is 20 mg/day for the immediate-release formulation, or 28 mg/day for the extended-release (XR) formulation. A handwritten notation to See Response was noted. There was no Physician's Response checked, no physician signature or date. Consultation Report dated 10/05/21 revealed the above recommendation. Physician's Response: I accept the recommendations above, please implement as written. Increase Memantine to 10 mg every AM and 5 mg PM, dated 10/05/21. These findings were verified on 06/15/22 at 2:53 P.M. by Regional Quality Assurance Nurse #553. The Regional Nurse stated the notation See Response for 08/03/21 reflected the Physician's Response dated 10/05/21. The Regional Quality Assurance Nurse stated she had been on maternity leave and when she came back, she had to follow-up on tasks that were incomplete. She stated the Director of Nursing and Assistant Director of Nursing were new to their roles and she had to train them. Review of facility policy titled Medication Regimen Reviews, dated 05/2019, revealed the Consultant Pharmacist reviews the medication regimen of each resident at least monthly. 1. The Consultant
Page 1 of 2
365297
365297
06/16/2022
Shelby Skilled Nursing and Rehabilitation
705 Fulton Street Sidney, OH 45365
F 0756
Level of Harm - Minimal harm or potential for actual harm
Residents Affected - Few
Pharmacist performs a medication regimen review (MRR) for every resident in the facility receiving medication. 2. Medication regimen reviews are done at least monthly, or more frequently if indicated. 3. The goal of the MMR is to promote positive outcomes while minimizing adverse consequences and potential risks associated with medication. 4. The MRR involves a thorough review of the resident's medical record to prevent, identify, report, and resolve medication related problems, medication errors and other irregularities, for example: medications a. ordered in excessive doses or without clinical indication; b. medication regimens that appear inconsistent with the resident's stated preferences; c. duplicative therapies or omissions of ordered medication; d. inadequate monitoring for adverse consequences; e. potentially significant drug-drug or drug-food interactions; f. potentially significant medication-related adverse consequences or actual signs and symptoms that could represent adverse consequences; g. incorrect medications, administration times or dosage forms; or other h. medication errors, including those related to documentation. 5. The medication regimen and associated treatment goals involve collaboration with the resident (or representative), family members, and the interdisciplinary team (IDT). As such, the MRR includes a review of the resident's (or representative's) stated preferences, the comprehensive care plans and information provided about the risks and benefits of the medication regimen. In addition to reviewing the medical record the Consultant Pharmacist may also meet with staff, the resident or representatives, or the IDT. 7. Within 24 hours of the MRR, the Consultant Pharmacist provides a written report to the attending physicians for each resident identified as having a non-life-threatening medication irregularity. The report contains: a. The resident's name; b. the name of the medication; c. the identified irregularity; and e. the pharmacist's recommendation. 8. An irregularity refers to the use of medication that is inconsistent with accepted pharmaceutical services standards or practice; is not supported by medical evidence; and/or impedes or interferes with achieving the intended outcomes of pharmaceutical services. It may also include the use of medication without indication, without adequate monitoring, in excessive doses, and or in the presence of adverse consequences. 10. If the physician does not provide a timely or adequate response, the Consultant Pharmacist identifies that no action has been taken, he/she contacts the Medical Director or (if the Medical Director is the physician of record) the Administrator. 11. The attending physician documents in the medical record that the irregularity has been reviewed and what (if any) action was taken to address it. 12. An acute change of condition may prompt a request for a MRR. The staff member who identifies the change of condition follows reporting procedures to notify the physician. The physician may request a MRR be conducted within a specific timeframe (e.g. within 24 hours).
365297
Page 2 of 2